Literature DB >> 8349840

Immunocytochemical staining of AII-amacrine cells in the rat retina with antibodies against parvalbumin.

H Wässle1, U Grünert, J Röhrenbeck.   

Abstract

The rod dominated rodent retina is the preferred tissue for in vitro studies of mammalian retinal physiology and pharmacology. The rod pathway through the rat retina was investigated, therefore, in order to find out whether its organization follows the mammalian "plan." AII-amacrine cells of the rat retina were injected with Lucifer Yellow to characterize the morphology of this bistratified interneuron of the rod pathway. When sections or whole mounts of the rat retina were stained with antibodies against the calcium binding protein parvalbumin (PV), two different amacrine cell types were labeled: the AII-amacrine cell and a widefield amacrine cell. They occur at a ratio of 12:1. Weak label was also observed in ganglion cells. The density of PV-labeled AII-cells decreases from approximately 7,000 cells/mm2 in upper central retina to 2,000 cells/mm2 in peripheral retina. Their cell bodies form a regular mosaic, and the dendritic arbors of three neighbouring AII-amacrine cells overlap (coverage of 3).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349840     DOI: 10.1002/cne.903320403

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  53 in total

1.  Depletion of cholinergic amacrine cells by a novel immunotoxin does not perturb the formation of segregated on and off cone bipolar cell projections.

Authors:  Emine Gunhan; Prabhakara V Choudary; Thomas E Landerholm; Leo M Chalupa
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

2.  GABAergic synapses made by a retinal dopaminergic neuron.

Authors:  Massimo Contini; Elio Raviola
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-23       Impact factor: 11.205

3.  Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha.

Authors:  Elizabeth K Lucas; Sean J Markwardt; Swati Gupta; James H Meador-Woodruff; Jiandie D Lin; Linda Overstreet-Wadiche; Rita M Cowell
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

4.  DARPP-32-like immunoreactivity in AII amacrine cells of rat retina.

Authors:  Gloria J Partida; Sherwin C Lee; Leah Haft-Candell; Grant S Nichols; Andrew T Ishida
Journal:  J Comp Neurol       Date:  2004-12-13       Impact factor: 3.215

5.  Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.

Authors:  Norbert Babai; Tamás Atlasz; Andrea Tamás; Dóra Reglödi; Gábor Tóth; Péter Kiss; Róbert Gábriel
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

6.  Amacrine cell subtypes differ in their intrinsic neurite growth capacity.

Authors:  Noelia J Kunzevitzky; Kevin T Willeford; William J Feuer; Monica V Almeida; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

7.  Association of connexin36 and zonula occludens-1 with zonula occludens-2 and the transcription factor zonula occludens-1-associated nucleic acid-binding protein at neuronal gap junctions in rodent retina.

Authors:  C Ciolofan; X-B Li; C Olson; N Kamasawa; B R Gebhardt; T Yasumura; M Morita; J E Rash; J I Nagy
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

8.  Identification of retinal neurons in a regressive rodent eye (the naked mole-rat).

Authors:  Stephen L Mills; Kenneth C Catania
Journal:  Vis Neurosci       Date:  2004 Mar-Apr       Impact factor: 3.241

9.  Natural sleep modifies the rat electroretinogram.

Authors:  R Galambos; G Juhász; A K Kékesi; G Nyitrai; N Szilágyi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure.

Authors:  María Hernandez; F David Rodriguez; S C Sharma; Elena Vecino
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.